"These initiatives and enhancements demonstrate our ongoing commitment to prioritising employee wellbeing."
- Rich Glassborow - AXA Health
AXA Health has announced additional testing and treatment options for employees with access to its men’s health, women’s health, fertility, menopause, pregnancy and early parenthood support services.
The updates, delivered in collaboration with Peppy, include men’s ultimate blood test, polyendocrine metabolic ovarian syndrome (PMOS) testing, personalised hormone replacement therapy (HRT) prescribing and treatment plans, semen testing, cholesterol testing and prostate specific-antigen (PSA) testing.
Additional updates include access to private prescriptions for HRT, contraception and men’s health treatments when clinically appropriate. All services are delivered digitally by Peppy's clinical practitioners.
READ MORE: Zurich launches pregnancy loss support ahead of Baby Loss Awareness Week
AXA Health says the updates come at no extra charge and are included within its existing standalone company paid men’s health, women’s health, fertility, pregnancy and early parenthood and menopause support services.
"These initiatives and enhancements demonstrate our ongoing commitment to prioritising employee wellbeing and ensuring people receive timely, expert support when they most need it," Rich Glassborow, distribution, propositions and marketing Director at AXA Health, said.
"By adding access to tests, treatment options and private prescriptions, we’re helping our clients’ employees get answers sooner, start the right treatment earlier and feel listened to and cared for throughout their health journey."
